טוען...
Allo‐reactive T cells for the treatment of hematological malignancies
Several mechanisms can be responsible for control of hematological tumors by allo‐reactive T cells. Following allogeneic stem cell transplantation (alloSCT) donor T cells recognizing genetic disparities presented on recipient cells and not on donor cells are main effectors of tumor control, but also...
שמור ב:
| הוצא לאור ב: | Mol Oncol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528734/ https://ncbi.nlm.nih.gov/pubmed/26578450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.10.014 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|